Oppenheimer raised the firm’s price target on Idex Corp. (IEX) to $242 from $230 and keeps an Outperform rating on the shares following quarterly results. The firm says that increasingly evident HST secular growth drivers, FMT’s shortcycle industrial leverage, and incremental/accretive capital deployment all support earnings and cash flow upside over the coming quarters.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IEX:
